WASHINGTON, D.C. — December 10, 2014 — The Sabin Vaccine Institute (Sabin) today announced that its Board of Trustees unanimously appointed Axel Hoos, MD, PhD, to serve as the interim Chairman of the Board. Building upon the past successes of late Chairman Morton P. Hyman, Dr. Hoos will be instrumental to providing continuity to the institute and to Sabin’s efforts in launching new programs, clinical trials and advocacy campaigns around the world.
Statements and Press Releases
Washington, DC - December 4, 2014 Four eminent scientists have agreed to serve as U.S. Science Envoys beginning in January, 2015: Dr. Peter Hotez, Dr. Jane Lubchenco, Dr. Arun Majumdar, and Dr. Geri Richmond. Announced by President Obama in Cairo in June 2009, the U.S. Science Envoy program demonstrates the United States’ commitment to science, technology, and innovation as tools of diplomacy and economic growth.
Morton P. Hyman, a renowned philanthropic and public health leader and Chairman of the Sabin Vaccine Institute Board of Trustees, passed away peacefully yesterday surrounded by his family and loved ones. The following is a statement from Sabin’s CEO, Ambassador Michael W. Marine, reflecting on the profound difference that Mort made during his lifetime.
WASHINGTON, D.C. — September 25, 2014 — The Sabin Vaccine Institute (Sabin) today announced that effective October 17, 2014, Dr. Jon Andrus will join Sabin as Executive Vice President and Director of Vaccine Advocacy and Education. In this role, he will leverage more than three decades of experience as a global health leader with a well-documented record for fostering collaboration among national governments and partners to expand access to vaccines for the world’s poorest people.